Perrigo | PRGO - Debt


Perrigo reported $3.64B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
Abbott USD 12.94B 496M Sep/2025
Bayer EUR 39.39B 1.31B Mar/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Coherus Biosciences USD 294.92M 1.25M Mar/2025
Corcept Therapeutics USD 6.36M 247K Sep/2025
Dr.Reddys Laboratories INR 67.73B 9.19B Dec/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
J&J USD 45.8B 4.97B Sep/2025
Merck USD 41.37B 5.97B Sep/2025
Nestle CHF 54.31B 285M Dec/2022
Pacira USD 372.19M 4.53M Dec/2025
Perrigo USD 3.64B 7.2M Sep/2025
Pfizer USD 60.85B 78M Sep/2025
Phibro Animal Health USD 474.17M 730K Sep/2024
Prestige Brands USD 1.04B 1.7M Sep/2025
Reckitt Benckiser GBP 8.66B 238M Dec/2024
Sanofi EUR 21.76B 530M Sep/2025
Supernus Pharmaceuticals USD 42.21M 10.44M Sep/2025
Teva Pharmaceutical Industries USD 17.07B 450M Sep/2025
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025
Zoetis USD 7.27B 482M Sep/2025